Cargando…
Graft-versus-cancereffect and innovative approaches in the treatment of refractorysolid tumors
BACKGROUND/AIM: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been used for the treatment of various refractory solid tumors during the last two decades. After the demonstration of graft-versus-leukemia (GvL) effect in a leukemic murine model following allo-HSCT from other strai...
Autores principales: | ŞAHİN, Uğur, DEMİRER, Taner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672351/ https://www.ncbi.nlm.nih.gov/pubmed/32178508 http://dx.doi.org/10.3906/sag-1911-112 |
Ejemplares similares
-
Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer
por: Karadurmus, Nuri, et al.
Publicado: (2016) -
A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer
por: Karadurmus, Nuri, et al.
Publicado: (2018) -
Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation
por: Cengiz Seval, Güldane, et al.
Publicado: (2018) -
Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma
por: Uckun, Fatih M., et al.
Publicado: (2018) -
A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017)